29 April – 1 May

UAEM European Conference
Berlin, Germany
MPP’s Advocacy Officer will be presenting on Sunday 1 May

Past events

Generics Bulletin: “Medicines Patent Pool has potential for wider scope”

Read the article

Expression of Interest

MPP invites Expressions of Interest from potential sub-licensees for the licence to manufacture and sell formulations containing lopinavir and ritonavir. 

MPP Submission to the UN High-Level Panel on Access to Medicines

Read the MPP submission.

MPP Newsletter – January 2016

One licence for a HCV medicine, two new disease areas, four new board members, $120 million in savings: check out MPP’s January newsletter for an update on top initiatives in Q3/Q4 2015.

Global Innovative Financing for the Next Decade

Greg Perry and Philippe Douste-Blazy in Global Health and Diplomacy Magazine

New agreements for TAF signed with Lupin and Micro Labs

View our sub-licensees section

Ensuring new medicines reach those in most need

Read MPP’s Executive Director, Greg Perry and Head of Policy, Esteban Burrone’s comment published in the  The Lancet HIV

ARV forcasts presented at IAS 2015

Forecasted demand for current and new ARV medicines in low- and middle-income countries, 2014-2025

UNITAID and MPP publish ARV Snapshot Report

See the report

MPP Newsletter July 2015

Review our progress over the past months: new publications, events & more